Deciphering Driver of Nasopharyngeal Cancer Development
- PMID: 36531162
- PMCID: PMC9756839
- DOI: 10.3389/or.2022.10654
Deciphering Driver of Nasopharyngeal Cancer Development
Abstract
A great deal of progress has been made on understanding nasopharyngeal cancer in recent decades. Genomic, transcriptomic, and proteomic studies have enabled us to gain a deeper understanding on the biology of nasopharyngeal cancer, and though this new information is elaborate and detailed, an overall picture of the driver of nasopharyngeal cancer that includes all this information is lacking. This review will focus on providing a broad overview, with plausible and simple language, on nasopharyngeal carcinogenesis based on current updated information. This will help readers to gain a broad understanding, which may be necessary to provide common ground for further research on nasopharyngeal cancer.
Keywords: EBV; HLA polymorphism; MHC; carcinogenesis; immunology; nasopharyngeal cancer.
Copyright © 2022 Handoko, Louisa, Permata and Gondhowiardjo.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
References
-
- Dittberner A, Friedl B, Wittig A, Buentzel J, Kaftan H, Boeger D, et al. Gender Disparities in Epidemiology, Treatment, and Outcome for Head and Neck Cancer in Germany: A Population-Based Long-Term Analysis from 1996 to 2016 of the Thuringian Cancer Registry. Cancers (2020) 1212(11):3418. 10.3390/cancers12113418 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
